NC

Naman Capital Portfolio holdings

AUM $308M
This Quarter Return
+6.05%
1 Year Return
+7.08%
3 Year Return
+92.27%
5 Year Return
+121.37%
10 Year Return
AUM
$104M
AUM Growth
+$104M
Cap. Flow
-$2.57M
Cap. Flow %
-2.46%
Top 10 Hldgs %
89.69%
Holding
13
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
$2.57M

Sector Composition

1 Healthcare 39.88%
2 Technology 19.5%
3 Consumer Staples 11.15%
4 Financials 7.59%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SH icon
1
ProShares Short S&P500
SH
$1.25B
$15.6M 14.95% 650,000
ATVI
2
DELISTED
Activision Blizzard Inc.
ATVI
$11.9M 11.38% 200,000
GILD icon
3
Gilead Sciences
GILD
$140B
$11M 10.58% 170,000
MRK icon
4
Merck
MRK
$210B
$10.9M 10.45% 120,000
BMY icon
5
Bristol-Myers Squibb
BMY
$96B
$10.3M 9.84% 160,000 -40,000 -20% -$2.57M
PFE icon
6
Pfizer
PFE
$141B
$9.4M 9.01% 240,000
ORCL icon
7
Oracle
ORCL
$635B
$8.48M 8.12% 160,000
DIS icon
8
Walt Disney
DIS
$213B
$7.23M 6.93% 50,000
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.09T
$4.53M 4.34% 20,000
BUD icon
10
AB InBev
BUD
$122B
$4.28M 4.09% 52,300
K icon
11
Kellanova
K
$27.6B
$4.15M 3.98% 60,000
BRK.A icon
12
Berkshire Hathaway Class A
BRK.A
$1.09T
$3.4M 3.25% 10
KHC icon
13
Kraft Heinz
KHC
$33.1B
$3.21M 3.08% 100,000